Reports
Sale
Global Biochip Market Size, Share, Trends, Forecast: By Technology: Microarray, Microfluidics; By Type: DNA Chips, Lab-On-a-Chips, Protein Chips, Others; By Applications: Drug Discovery and Development, Disease Diagnostics, Genomics, Proteomics, Others; By End User; Regional Analysis; Market Dynamics; Supplier Landscape; 2024-2032
Global Biochip Market Outlook
The global biochip market size was valued at USD 14.43 billion in 2023, driven by the increasing demand for personalized medicines across the globe. The market size is anticipated to grow at a CAGR of 11.84% during the forecast period of 2024-2032 to achieve a value of USD 55.38 billion by 2032.
Biochip: Introduction
A collection of microarrays that are arranged on a solid substrate allows the execution of multiple tests simultaneously in order to achieve a higher performance speed. Generally, the surface area of a biochip is as big as a thumbnail. Biochips can be looked at as the utilization of microchip technology on the microbiology.
Biochips can also be used in the breeding of plants and animals, along with use in food and environment monitoring. A single biochip has an alphanumeric 10-digit identification code, which never repeats and cannot be duplicated as well. The biochip is analyzed by a computer. When a biochip is passed through a scanner, the biochip's identification flashes on the computer screen, followed by a beep sound. Those thousands of biological reactions taking place on the surface of a biochip help the computer to analyze the reaction in a minimum time span.
Global Biochip Market Analysis
The accuracy of biochip and the comparison of it with PCR testing is a major driver aiding the market growth. Biochip and its increasing collaborations with different technologies is expected to propel the global biochip market growth. The involvement of machine learning in detection technology is majorly contributing to the growth of the market. Biochip finds wide application in the development of precision medicine. Biochips find their wide application in the field of proteomics, genomics, and drug discovery. The increasing drug development for critical illness disease like cancer is driving the market growth for biochips globally as it helps in the development of personalized medicine for cancer patients. The increased utilization of next generation sequencing in research and development of drugs and treatments for cancer patient and other chronic illnesses has been driving the market growth.
Additionally, the increasing prevalence of chronic diseases, like cancer and cardiovascular diseases, are contributing to the market global biochip market expansion. The use of biochip technology helps in early detection of these chronic diseases, which help the patients to avail early treatments for their disease. With the global recognition of the efficacy of biochips, healthcare professionals and research institutes are increasingly adopting this technology. This rapid rise in the popularity of biochips is directly contributing to the market growth.
Global Biochip Market Segmentations
Market Breakup by Technology
- Microarray
- Microfluidics
Market Breakup by Type
- DNA Chips
- Lab-On-a-Chips
- Protein Chips
- Others
Market Breakup by Applications
- Drug Discovery and Development
- Disease Diagnostics
- Genomics
- Proteomics
- Others
Market Breakup by End User
- Hospitals and Diagnostic Centers
- Academics and Research Institutes
- Biotechnology and Pharmaceutical Companies
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Biochip Market Overview
The market plays an important role and provides many opportunities to the healthcare industry globally. The growth of the market is driven by factors like rising competition amongst the key players, increasing drug development, and increasing demand for personalized medicines in the market, along with next-generation sequencing (NGS). The Lab-on-a-chip is developing innovations, which is the biomedical advancement for microfluidic-based devices. These innovations are expected to contribute to the biochip market development. Lab-on-a-chip LOC devices are known for their fast result generation at the initial diagnosis of infectious diseases. These innovative technologies are greatly used for epidemiological studies.
Global Biochip Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Abbott Laboratories Inc.
- Agilent Technologies, Inc.
- PerkinElmer Inc.
- Fluidigm Corporation
- Illumina, Inc.
- GE Healthcare Inc.
- Bio-Rad Laboratories Inc.
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche AG
- BioMérieux SA
- HORIBA, Ltd.
- QIAGEN N.V.
- Randox Laboratories Ltd.
- OriGene Technologies, Inc.
- Cepheid (Danaher Corporation)
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Technology |
|
| Breakup by Type |
|
| Breakup by Applications |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Biochip Market Overview
3.1 Global Biochip Market Historical Value (2017-2023)
3.2 Global Biochip Market Forecast Value (2024-2032)
4 Global Biochip Market Landscape
4.1 Global Biochip Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Biochip Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Biochip Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Biochip Market Segmentation
6.1 Global Biochip Market by Technology
6.1.1 Market Overview
6.1.2 Microarray
6.1.3 Microfluidics
6.2 Global Biochip Market by Type
6.2.1 Market Overview
6.2.2 DNA Chips
6.2.3 Lab-On-a-Chips
6.2.4 Protein Chips
6.2.5 Others
6.3 Global Biochip Market by Applications
6.3.1 Market Overview
6.3.2 Drug Discovery and Development
6.3.3 Disease Diagnostics
6.3.4 Genomics
6.3.5 Proteomics
6.3.6 Others
6.4 Global Biochip Market by End User
6.4.1 Market Overview
6.4.2 Hospitals and Diagnostic Centers
6.4.3 Academics and Research Institutes
6.4.4 Biotechnology and Pharmaceutical Companies
6.4.5 Others
6.5 Global Biochip Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Biochip Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Biochip Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Biochip Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Biochip Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Biochip Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Abbott Laboratories Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Agilent Technologies, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 PerkinElmer Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Fluidigm Corporation
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Illumina, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 GE Healthcare Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Bio-Rad Laboratories Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Thermo Fisher Scientific, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 F. Hoffmann-La Roche AG
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 BioMérieux SA
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 HORIBA, Ltd.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 QIAGEN N.V.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Randox Laboratories Ltd.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 OriGene Technologies, Inc.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Cepheid (Danaher Corporation)
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Biochip Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of USD 14.43 billion in 2023, driven by the rising technological advancements in the market.
The market is anticipated to grow at a CAGR of 11.84% during the forecast period of 2024-2032 to attain a value of USD 55.38 billion by 2032.
The growth of the market is driven by factors like rising technological advancements, rising product innovations, and the increasing demand for personalized medicines.
The biochip and its collaborations with different technologies is a major trend in the market.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is the major regional market.
The different types of technologies that are used in the market are microarrays and microfluidics.
The different types of biochips in the market are DNA chips, lab-on-a-chips, and protein chips among others.
Biochips find wide application in drug discovery and development, disease diagnostics, genomics, and proteomics, among others.
The different end-users of the market include hospitals and diagnostic centers, academics and research institutes, biotechnology and pharmaceutical companies, among others.
Key players involved in the market are Abbott Laboratories Inc., Agilent Technologies, Inc., PerkinElmer Inc., Fluidigm Corporation, Illumina, Inc., GE Healthcare Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG, BioMérieux SA, HORIBA, Ltd., QIAGEN N.V., Randox Laboratories Ltd., OriGene Technologies, Inc., and Cepheid (Danaher Corporation).
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5999
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 7999
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9999
$5999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER